Related Experiment Video
Updated: Jul 9, 2025

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Maculopapular Drug Eruption Caused by Finasteride: A Case Report
1Department of Dermatology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China.
A 76-year-old man experienced a maculopapular rash after taking Finasteride for benign prostatic hyperplasia. This case suggests Finasteride can cause drug exanthema, a type of pharmacologic eruption.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Benign prostatic hyperplasia (BPH) is common in older men.
- Finasteride is a 5α-reductase inhibitor used to treat BPH.
Observation:
- A 76-year-old male presented with a maculopapular rash on his trunk and extremities.
- The rash emerged two months after initiating Finasteride therapy.
Findings:
- Clinical suspicion pointed towards a drug exanthema caused by Finasteride.
- Clinical and histological findings confirmed a pharmacologic eruption attributed to Finasteride.
Implications:
- This case highlights the potential for Finasteride to induce cutaneous adverse drug reactions.
- Awareness of drug exanthema is crucial for clinicians managing patients on Finasteride.
Related Concept Videos
Allergic Drug Reactions
Drug Excretion: Miscellaneous Routes
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Drugs for Treatment of Constipation-Predominant IBS

